Major Ingredients

Neomycin Sulphate 35,000 I.U.+ Polymyxin B Sulphate 35,000 I.U. + Nystatin 1,00,000 I.U. + Metronidazole 200 mg.

Major Functionality

Gynomix is indicated for the treatment of Vaginal mixed infections, Vaginal leucorrhoeas, Vaginal trichomoniasis if whatever their origin (Mycotic or Bacterial).

Manufacture Information

Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.